CUTANEOUS LEISHMANIASIS
Clinical trials for CUTANEOUS LEISHMANIASIS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LEISHMANIASIS trials appear
Sign up with your email to follow new studies for CUTANEOUS LEISHMANIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needle injection trial aims to heal parasitic skin sores
Disease control Recruiting nowThis study is testing whether injecting an antibiotic called levofloxacin directly into skin lesions can treat cutaneous leishmaniasis, a parasitic skin infection. The trial will involve 40 participants with up to six lesions each, who will receive weekly injections for up to six…
Matched conditions: CUTANEOUS LEISHMANIASIS
Phase: PHASE2 • Sponsor: Hayder Adnan Fawzi • Aim: Disease control
Last updated Apr 02, 2026 07:12 UTC
-
Antibiotic shot tested for parasitic skin disease
Disease control Recruiting nowThis study is testing if a local injection of an antibiotic called ciprofloxacin can heal skin sores caused by leishmaniasis. It will be compared directly to the standard local injection treatment. The trial will involve 80 people with up to six skin lesions, who will be followed…
Matched conditions: CUTANEOUS LEISHMANIASIS
Phase: PHASE2 • Sponsor: Al-Mustafa University College • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC